17-60181552-C-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_032582.4(USP32):c.4320G>T(p.Glu1440Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000144 in 1,461,672 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032582.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USP32 | NM_032582.4 | c.4320G>T | p.Glu1440Asp | missense_variant | 32/34 | ENST00000300896.9 | NP_115971.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USP32 | ENST00000300896.9 | c.4320G>T | p.Glu1440Asp | missense_variant | 32/34 | 1 | NM_032582.4 | ENSP00000300896.3 | ||
USP32 | ENST00000592339.5 | c.3330G>T | p.Glu1110Asp | missense_variant | 24/26 | 1 | ENSP00000467885.1 | |||
USP32 | ENST00000593071.1 | c.120G>T | p.Glu40Asp | missense_variant | 1/2 | 5 | ENSP00000466740.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251124Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135726
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461672Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 727146
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 22, 2024 | The c.4320G>T (p.E1440D) alteration is located in exon 32 (coding exon 32) of the USP32 gene. This alteration results from a G to T substitution at nucleotide position 4320, causing the glutamic acid (E) at amino acid position 1440 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at